The gut microbiota is a complex ecosystem that has coevolved with host physiology. Colonization of germ-free (GF) mice with a microbiota promotes increased vessel density in the small intestine 1 , but little is known about the mechanisms involved. Tissue factor (TF) is the membrane receptor that initiates the extrinsic coagulation pathway 2 , and it promotes developmental and tumour angiogenesis 3, 4 .
Here we show that the gut microbiota promotes TF glycosylation associated with localization of TF on the cell surface, the activation of coagulation proteases, and phosphorylation of the TF cytoplasmic domain in the small intestine. Anti-TF treatment of colonized GF mice decreased microbiota-induced vascular remodelling and expression of the proangiogenic factor angiopoietin-1 (Ang-1) in the small intestine. Mice with a genetic deletion of the TF cytoplasmic domain or with hypomorphic TF (F3) alleles had a decreased intestinal vessel density. Coagulation proteases downstream of TF activate protease-activated receptor (PAR) signalling implicated in angiogenesis 5 . Vessel density and phosphorylation of the cytoplasmic domain of TF were decreased in small intestine from PAR1-deficient (F2r
2/2
) but not PAR2-deficient (F2rl1 2/2 ) mice, and inhibition of thrombin showed that thrombin-PAR1 signalling was upstream of TF phosphorylation. Thus, the microbiota-induced extravascular TF-PAR1 signalling loop is a novel pathway that may be modulated to influence vascular remodelling in the small intestine.
The mammalian intestine is an organ with marked postnatal vascular adaptation, which is induced at weaning and coincides with the development of an adult microbiota. In agreement with early studies showing that the gut microbiota affects vascular remodelling in the intestine 1 , we showed significant increases in villus width in the small intestine of conventionally raised (CONV-R) mice in comparison with GF mice (Fig. 1a) , suggesting a link between vascular remodelling and altered villus architecture on colonization. We also showed increased staining and messenger RNA levels of the vascular marker plateletendothelial cell adhesion molecule 1 (PECAM-1) in the small intestine of both CONV-R and conventionalized (CONV-D; GF mice that had been colonized for 14 days with a normal microbiota from a CONV-R mouse) mice in comparison with GF mice (Fig. 1b-d) . The increased vessel density was located to the mid-distal part of the small intestine ( Supplementary Fig. 1 ). Staining for the tip-cell marker delta-like ligand 4 (Dll4) 6 indicated that colonization initially promoted sprouting angiogenesis but that the number of tip cells returned to basal levels once villus remodelling was complete (Fig. 1e) .
We found increased levels of mRNA for Ang-1 as well as increased phosphorylation of the Ang-1 receptor Tie-2 in the small intestine of CONV-R in comparison with GF mice (Fig. 1f, g ), thus providing a potential mechanism for microbiota-induced vascular remodelling. Consistent with increased vessel density, vascular endothelial growth factor receptor 1 (VEGFR-1) expression was also higher in CONV-R mice, but there were no changes in any other components of the VEGF pathway ( Supplementary Fig. 2 ). The Ang-1-Tie-2 axis promotes the remodelling and sprouting of blood vessels 7, 8 . To confirm a role for Ang-1 in microbiota-induced vascular remodelling, we injected GF mice with the specific Ang-1 inhibitor mL4-3 before and during a 14-day colonization with a normal gut microbiota and showed decreases in Tie-2 phosphorylation and intestinal vessel density ( Fig. 1h-j) . We identified the epithelium as a source of Ang-1, because its expression was increased in isolated primary enterocytes from CONV-R mice in comparison with those from GF mice (Fig. 1k) .
Angiogenesis is linked to the cellular initiation of coagulation, and TF signalling has been shown to modulate angiogenesis 3, 4 . Because bacterial components are known to stimulate the coagulation system 9 , we speculated that TF could have a function in microbiota-induced angiogenesis in the intestine. In agreement with earlier studies of TF localization in humans 10 and mice 11 , we identified TF predominantly in enterocytes of the villi of small intestine in both GF and CONV-R mice ( Supplementary Fig. 3 ). We injected GF mice with anti-TF antibody or control IgG before and at 4 and 9 days after colonization with a normal caecal microbiota. Tissues were harvested 14 days after colonization, and we confirmed that the injected antibodies localized to the small intestine ( Supplementary Fig. 4 ). Anti-TF treatment did not affect PECAM-1 staining in GF mice that were not colonized (Fig. 1l, m) ; neither were levels of VEGF-A, VEGFR-2 or VEGFR-3 mRNA in CONV-D mice affected ( Supplementary Fig. 5 ). However, anti-TF treatment decreased villus width (Fig. 1n) , vessel density (Fig. 1o, p) and expression of PECAM-1 and Ang-1 mRNA (Fig. 1q, r) in CONV-D mice, suggesting that TF promotes microbiota-induced remodelling of the villus vasculature. Similarly, the vessel density was decreased in intestines from mice expressing low levels of human TF (low-TF mice) 12 compared with mice expressing normal levels of human TF from a knocked-in minigene 13 (Supplementary Fig. 6 ). Because neither humanized mouse strain expressed alternatively spliced TF, intestinal vascular remodelling seems to be independent of alternatively spliced TF 14 . Paneth cells have been suggested to regulate microbiota-induced intestinal angiogenesis in mice, but they also have a large effect on angiogenesis independently of colonization status 1 . Anti-TF treatment did not decrease the number of Paneth cells or mRNA levels of Paneth cell-derived cryptdin 2 in CONV-D mice ( Supplementary Fig. 7 ), indicating that treatment with antibody has no cytotoxic effect on Paneth cells. In addition, vessel density was similar in colonized CR2-tox176 transgenic mice, which lack Paneth cells 15 , and their wild-type littermates after treatment with anti-TF ( Supplementary Fig. 8 ).
Next we investigated whether intestinal TF expression and activity differed between GF and CONV-R mice. We did not observe any differences in intestinal levels of mRNA for TF from the two groups of mice (Fig. 2a) . In contrast, immunoblot analyses identified two TFreactive bands, one with an apparent molecular mass of 33 kDa that was present in both groups and a second band with an apparent molecular mass of 46 kDa that was present at higher levels in intestinal lysates from CONV-R and CONV-D mice (Fig. 2b, c) . The gut microbiota has global effects on protein glycosylation in the small intestine 16 , which is necessary for the correct cellular localization and function of many proteins including TF procoagulant activity 17 . We therefore speculated that the 46-kDa TF band resulted from microbiotainduced N-linked glycosylation of TF, the primary carbohydrate modification of TF 17 . In agreement with this, the mannose-binding lectin concanavalin A readily detected the 46-kDa form of TF in . e, Dll4 staining (green) of sections of small intestine from GF, ex-GF mice colonized for 3 days (3d), and CONV-R mice. Endothelial cells were stained with PECAM-1 (red). Dll4-positive endothelial cells per 100 villi were quantified (n 5 3 mice per group). f, Relative levels of mRNA for Ang-1 in sections of small intestine from GF and CONV-R mice (n 5 7-11 mice per group). g, Anti-phospho-Tie-2 immunoblot (Y1100 phosphorylation site) and quantification relative to total Tie-2 of smallintestinal lysates from GF and CONV-R mice (n 5 5 mice per group). h, PECAM-1 staining of sections of small intestine from mice treated with control NaCl solution or the Ang-1 neutralizing peptibody mL4-3. i, Quantification of h (n 5 6 mice per group). j, Relative levels of mRNA for PECAM-1 in sections of small intestine from CONV-D mice treated with NaCl control or mL4-3 (n 5 10 or 11 mice per group). The inset shows that mL4-3 is a potent inhibitor of Ang-1-mediated Tie-2 phosphorylation. k, Relative levels of mRNA for Ang-1 in primary enterocytes from GF and CONV-R mice (n 5 10 or 11 mice per group). l, PECAM-1 staining of sections of small intestine from GF mice treated with control or anti-TF antibody. m, Quantification of l (n 5 6 or 7 mice per group). n, Villus width of sections of small intestine from CONV-D mice treated with control or anti-TF antibody (n 5 4 mice per group). o, PECAM-1 staining of sections of small intestine from CONV-D mice treated with control or anti-TF antibody. p, Quantification of o (n 5 7 mice per group). q, r, Relative levels of mRNA for PECAM-1 (q) and Ang-1 (r) in small intestine from CONV-D mice treated with control or anti-TF antibody (n 5 5 or 6 mice per group). Female Swiss Webster mice or cells isolated from these mice were analysed in all panels. Scale bars, 50 mm. Results are shown as means 6 s.e.m. Asterisk, P , 0.05; two asterisks, P , 0.01; three asterisks, P , 0.005; n.s., not significant.
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small-intestinal lysates from CONV-D mice ( Supplementary Fig. 9a ). Treatment with the N-glycosidase PNGase F abolished detection of the 46-kDa form and generated a partly deglycosylated form with increased electrophoretic mobility that was only weakly detected by concanavalin A. We also treated primary enterocytes from CONV-R mice with the N-glycosylation inhibitor tunicamycin and observed a decreased abundance of the 46-kDa form ( Supplementary Fig. 9b, c) . These findings indicate that the gut microbiota promotes Nglycosylation of TF. Exposure of functional TF on cell surfaces is regulated by basolateral sorting in epithelial cells 18 . Surface biotinylation followed by biotin pull-down of primary enterocytes from GF mice showed that the underglycosylated TF was mainly intracellular (Fig. 2d, e) . In contrast, surface labelling of proteins or carbohydrates showed that enterocytes from CONV-R mice had high levels of the fully glycosylated TF on the cell surface (Fig. 2d, e and Supplementary Fig. 10 ). Confocal microscopy confirmed plasma membrane localization of TF in primary enterocytes isolated from CONV-R mice ( Supplementary Fig. 11 and Supplementary Movie). These changes were associated with enhanced coagulation activation, as demonstrated by increased TFFVIIa-dependent generation of coagulation factor Xa and higher levels of thrombin-antithrombin complexes in lysates of small intestine from CONV-R in comparison with those from GF mice (Fig. 2f,g ).
Not only does TF initiate coagulation, it also interacts with integrins on the extracellular side and regulates integrin function through its cytoplasmic domain 19 . Proximity ligation and immunoprecipitation experiments showed increased TF-b 1 integrin complex formation in intestinal tissue from CONV-R mice in comparison with GF counterparts (Supplementary Fig. 12a, b) . Furthermore, TF-b 1 integrin complex formation was decreased by treating CONV-R mice with tunicamycin ( Supplementary Fig. 12c ). The cytoplasmic domain of TF contains a conserved Ser/Thr-Pro phosphorylation site 20 . Phosphorylation of this domain has been observed at sites of neovascularization 4 ; it requires surface localization of TF 21 and regulates integrin function 19 . An antibody directed against the phosphorylated domain of mouse TF detected increased phosphorylation in the 46-kDa form of TF in lysates of small intestine from CONV-R in comparison with that from GF mice (Fig. 3a) , and treatment of primary enterocytes from CONV-R mice with tunicamycin decreased levels of the phosphorylated 46-kDa form of TF (Fig. 3b, c) .
To test directly whether the TF cytoplasmic domain was involved in vascular remodelling, we analysed small-intestinal tissue from mice with a targeted deletion of this domain (DCT mice) 22 and age-matched wildtype mice. DCT mice had significantly decreased villus vascularization (Fig. 3d, e) and decreased expression of mRNA for PECAM-1 and Ang-1 in comparison with wild-type mice (Fig. 3f) . TF from wild-type and DCT mice had similar electrophoretic mobilities (Supplementary Fig. 13 ). These data show that the TF cytoplasmic domain has a function in increasing vessel density in the small intestine but that it is not required for glycosylation. Anti-TF treatment decreased TF phosphorylation but not total TF levels in CONV-D mice (Supplementary Fig. 14) . These results indicate that the inhibitory effects of anti-TF on vascular remodelling are independent of TF downregulation but, at least in part, involve inhibition of TF cytoplasmic domain phosphorylation.
TF also mediates signalling through coagulation proteases that activate the G-protein-coupled receptors PAR1 and PAR2 (refs 4, 5). We investigated the effect of the gut microbiota on PAR expression in small-intestinal tissue. Levels of mRNA for PAR1 but not those for PAR2 were increased in CONV-R mice in comparison with GF 
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counterparts (Fig. 4a) . PAR1 is abundantly expressed in endothelial cells 5 , but we found that PAR1 was also expressed in enterocytes and at higher levels in cells from CONV-R mice than in GF counterparts ( Supplementary Fig. 15 ). PECAM-1 staining (Fig. 4b, c) as well as levels of mRNA for PECAM-1 and Ang-1 (Fig. 4d, e) were decreased in intestinal tissue from PAR1-deficient (F2r
) mice, which is in agreement with a study showing that thrombin induces PAR1-dependent Ang-1 expression in endothelial cells 23 . Together, these data show that the microbiota induces increased expression of PAR1, and that PAR1 has a role in remodelling the vasculature in the small intestine.
We next investigated the potential interrelation between PAR1 and TF in intestinal tissue. Phosphorylation of TF was decreased in lysates of small intestine from F2r 2/2 in comparison with that from wild-type and F2rl1 2/2 mice (Fig. 4f) , indicating that PAR1 acts upstream of TF phosphorylation. We blocked thrombin and thrombin-dependent PAR1 signalling with hirudin immediately before and during colonization of GF mice for 6 h, and observed a striking decrease in TF phosphorylation in lysates of small intestine (Fig. 4g, h ). We also showed that thrombin increased the phosphorylation of TF in primary enterocytes (Fig. 4i, j) . Taken together, these data suggest that functional, procoagulant TF is required for the generation of thrombin, which in turn activates PAR1 to promote phosphorylation of the cytoplasmic domain of TF in enterocytes.
This study has uncovered a novel connection between TF, PAR1 and Ang-1 in modulating vascular remodelling after colonization. Our results support a model in which the microbiota induces increased glycosylation and surface localization of TF in the small intestine, leading to activation of coagulation, PAR1-dependent-phosphorylation of the TF cytoplasmic domain, and TF cytoplasmic domain signalling linked to Ang-1-dependent vascular remodelling (Supplementary Fig. 16 ). This pathway is distinct from established models of ocular angiogenesis 4 or tumour-induced neovascularization, which requires the TF-Factor VIIa-PAR2-mediated induction of proangiogenic chemokines 24 . We therefore suggest that TF may support distinct pro-angiogenic pathways in different tissues. Increased vascularization of the villi of the small intestine increases oxygenation of the villi, which are shortened and widened after colonization. This process may promote increased nutrient absorption, which has been associated with increased adiposity in CONV-R mice 25 . Further dissection of how TF and PAR1 mediate postnatal microbiota-induced angiogenesis may provide new therapeutic targets for improving intestinal homeostasis and modulating the absorptive capacity of the gut.
METHODS SUMMARY
Mice. GF Swiss Webster female mice were maintained in flexible film isolators under a 12-h light cycle and fed with an autoclaved chow diet (Labdiet, St Louis) ad libitum. CONV-R Swiss Webster female mice were transferred into identical isolators at weaning. Age-matched female DCT (ref. 22 , and transgenic CR2-tox176 and non-transgenic littermates on a FVB/N genetic background 15 were also used. 
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Mice were killed at 10-14 weeks of age by cervical dislocation or overdose anaesthesia; small intestines were removed and divided into eight equal segments. The fifth segment was used unless otherwise stated. Animal protocols were approved by the Research Animal Ethics Committee in Gothenburg and the Scripps Research Institute Institutional Animal Care and Use Committee (IACUC). Isolation of primary enterocytes. Enterocytes were isolated from the fifth segment of small intestine as described previously 28 . The cells were cultured for 2 h in DMEM medium before the beginning of the experiment. Administration of TF antibody. Rabbit anti-mouse TF antibody 29 or rabbit anti-mouse IgG (Sigma) (1.33 mg per kg body weight) were administered intraperitoneally to GF mice before conventionalization with a caecal microbiota from a CONV-R donor. Additional antibody injections were given 4 and 9 days after colonization. The mice were killed 14 days after colonization. Statistics. Data were analysed with Student's t-test for two sample groups or oneway analysis of variance for three sample groups.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Administration of mL4-3. mL4-33 (ref. 30) (2.32 mg per kg body weight) was administered subcutaneously to GF mice before conventionalization with a caecal microbiota from a CONV-R donor. Additional injections of mL4-3 were given three times a week. The mice were killed 14 days after colonization. Preparation of intestinal samples. For immunohistochemistry and in situ hybridization, the small intestine (divided into eight equal segments) and colon were flushed with PBS after excision and opened longitudinally. The tissue was fixed overnight in 4% formaldehyde at 4 uC, washed three times in PBS, and incubated in 10% sucrose in PBS at 4 uC. After 3 h, the buffer was replaced with 20% sucrose and 10% glycerol in PBS, and the tissue was incubated at 4 uC overnight. Tissues were dried with a paper towel and mounted in OCT on solid CO 2 . Frozen sections 6 mm thick were prepared.
For mRNA analyses, the segments were frozen immediately at 280 uC in liquid nitrogen. For immunoblots, the fifth segment was flash-frozen and homogenized for 10 min in lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100) containing Roche Complete protease and PhosStop phosphatase inhibitors (diluted 1:10). The homogenate was incubated for 30 min on ice and centrifuged three times at 9,000g for 10 min to remove insoluble cell debris. Immunohistochemistry. Sections were incubated for 20 min at 22 uC and blocked for 1 h with diluted TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton X-100) containing 5% rabbit serum. The blocking solution was removed and the following primary antibodies, diluted in the same blocking solution, were added: rat anti-mouse PECAM-1 (dilution 1:300; BD, Franklin Lakes), chicken anticytokeratin 8 (dilution 1:100; Abcam, Cambridge), goat-anti DLL4 (dilution 1:50; R&D), rabbit anti-mouse TF 29 (1 mg ml 21
